U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

PXS-4728A FREE BASE

MORE DETAILS

MFI2XG2PVK

Status:
Investigational
Source:
NCT03238963: Phase 2 Interventional Completed Diabetic Retinopathy
(2017)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT03238963
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Membrane primary amine oxidase
2

PXS-4728A

MORE DETAILS

6W2049SJPH

Status:
Investigational
Source:
NCT03238963: Phase 2 Interventional Completed Diabetic Retinopathy
(2017)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT03238963
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Membrane primary amine oxidase
2
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966